Canadian International Pharma Corp. announced earnings results for the second quarter ended April 30, 2019. For the second quarter, the company announced net loss was CAD 40,865 compared to CAD 55,461 a year ago. For the half year, net loss was CAD 88,268 compared to CAD 120,133 a year ago. Basic eps was CAD 0 compared to basic loss per share of CAD 0.01 a year ago.